Php358 - Time-Limited G-Ba Resolutions – A Tool to Appropriately Manage Reimbursement of Innovative Therapies Receiving Expedited Regulatory Approval

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1252
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Php357 - Making Sense From Anti-Sense: Lessons in Translating Expedited Regulatory Approval Into Reimbursement and Commercial Success

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Breakthrough Therapy Status €“ Expedited FDA Regulatory Approval but What About the Payers?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Php224 - Temporary Access Structures for Innovative, High-Value Therapies: Comparison of Models and Consequent Reimbursement Timelines

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Tool to Manage Tasks of R&D Projects

CIM Series in Mathematical Sciences
2015English

Safety Related Label Changes for New Drugs After Approval in the US Through Expedited Regulatory Pathways: Retrospective Cohort Study

British Medical Journal
Medicine
2017English

Understanding Trapping as a Tool to Manage Pocket Gophers

Proceedings of the Vertebrate Pest Conference
2014English

Analysis of Time to Regulatory and Ethical Approval of SATVI TB Vaccine Trials in South Africa

South African Medical Journal
Medicine
2012English

Php140 - Current Challenges and Potential Solution for Pricing Regulatory and Reimbursement Framework of Innovative Drugs in Egypt

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Survey of Innovative Reimbursement Models in Spine Care

Spine
OrthopedicsNeurologySports MedicineSports Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy